Free Cash Flow (Quarterly) Chart

View Free Cash Flow (Quarterly) for PTN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow (Quarterly) Chart
Start Trial

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2026 -4.456M
December 31, 2025 -4.820M
September 30, 2025 -1.619M
June 30, 2025 -4.089M
March 31, 2025 -5.354M
December 31, 2024 -4.847M
September 30, 2024 -7.016M
June 30, 2024 -6.477M
March 31, 2024 -8.607M
December 31, 2023 -10.51M
September 30, 2023 -5.906M
June 30, 2023 -9.658M
March 31, 2023 -1.525M
December 31, 2022 -9.799M
September 30, 2022 -8.722M
June 30, 2022 -7.756M
March 31, 2022 -9.569M
December 31, 2021 -6.378M
September 30, 2021 -6.481M
June 30, 2021 -8.536M
March 31, 2021 -3.510M
December 31, 2020 -14.42M
September 30, 2020 3.813M
June 30, 2020 -6.076M
March 31, 2020 -2.512M
Date Value
December 31, 2019 -4.922M
September 30, 2019 54.77M
June 30, 2019 -6.945M
March 31, 2019 -3.845M
December 31, 2018 -5.491M
September 30, 2018 -5.538M
June 30, 2018 10.48M
March 31, 2018 -7.232M
December 31, 2017 -2.993M
September 30, 2017 1.425M
June 30, 2017 -13.02M
March 31, 2017 43.50M
December 31, 2016 -11.13M
September 30, 2016 -6.599M
June 30, 2016 -13.70M
March 31, 2016 -10.22M
December 31, 2015 -14.05M
September 30, 2015 -9.416M
June 30, 2015 -9.471M
March 31, 2015 -5.309M
December 31, 2014 -4.303M
September 30, 2014 5.725M
June 30, 2014 -4.520M
March 31, 2014 -1.495M
December 31, 2013 -4.147M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Decoy Therapeutics, Inc. -2.694M
ACADIA Pharmaceuticals, Inc. 95.69M
Alnylam Pharmaceuticals, Inc. 292.04M
Anika Therapeutics, Inc. -2.133M
Savara, Inc. -29.97M